Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

CompletedOBSERVATIONAL
Enrollment

446

Participants

Timeline

Start Date

December 26, 2016

Primary Completion Date

July 6, 2018

Study Completion Date

July 6, 2018

Conditions
Ovarian Cancer
Trial Locations (35)

Unknown

Research Site, Aichi

Research Site, Akita

Research Site, Aomori

Research Site, Chiba

Research Site, Fukuoka

Research Site, Fukushima

Research Site, Gifu

Research Site, Hyōgo

Research Site, Ibaraki

Research Site, Izumo

Research Site, Kanagawa

Research Site, Kumamoto

Research Site, Kyoto

Research Site, Maebashi

Research Site, Matsuyama

Research Site, Mie

Research Site, Miyagi

Research Site, Morioka

Research Site, Nagano

Research Site, Nagasaki

Research Site, Nara

Research Site, Niigata

Research Site, Okayama

Research Site, Okinawa

Research Site, Osaka

Research Site, Saga

Research Site, Saitama

Research Site, Sapporo

Research Site, Sendai

Research Site, Tochigi

Research Site, Tokushima

Research Site, Tokyo

Research Site, Tottori

Research Site, Tōon

Research Site, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY